SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU) - moderated
IMMU 18.28-1.5%Jan 24 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: trickydick12/7/2019 9:37:17 AM
   of 53762
 
Another thought crossed my feeble brain. Now that submission is done and virtually all commentary is more positive, would the people working for IMMU see the finish line and are racing to the finish and now buying into the company? Are there enough people in the market who have been following IMMU for years and have now made their move? The trading volume has been very strong over the past week, much of which was due to the submission, but, are the people who have been on the side lines have now moved in? Are there enough of these people to influence the price movement? Have institutional investors seen the risk factor go down dramatically? I agree we're on an upward trajectory, it's just those bumps in the road! Trying to get a more thoughts. It's been a long, agonizing struggle, but, the finish line is in sight. What a Christmas present it would be to get FDA approval by the time Santa is flying about delivering presents. Approval would be like getting that perfect gift you always wanted as a child. Hope upon hope!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext